| Literature DB >> 31777919 |
Elisé P Wright1, Mahmoud A S Abdelhamid1,2, Michelle O Ehiabor1, Melanie C Grigg3, Kelly Irving3, Nicole M Smith3, Zoë A E Waller1,2.
Abstract
i-Motifs are widely used in nanotechnology, play a part in gene regulation and have been detected in human nuclei. As these structures are composed of cytosine, they are potential sites for epigenetic modification. In addition to 5-methyl- and 5-hydroxymethylcytosine modifications, recent evidence has suggested biological roles for 5-formylcytosine and 5-carboxylcytosine. Herein the human telomeric i-motif sequence was used to examine how these four epigenetic modifications alter the thermal and pH stability of i-motifs. Changes in melting temperature and transitional pH depended on both the type of modification and its position within the i-motif forming sequence. The cytosines most sensitive to modification were next to the first and third loops within the structure. Using previously described i-motif forming sequences, we screened the MCF-7 and MCF-10A methylomes to map 5-methylcytosine and found the majority of sequences were differentially methylated in MCF7 (cancerous) and MCF10A (non-cancerous) cell lines. Furthermore, i-motif forming sequences stable at neutral pH were significantly more likely to be epigenetically modified than traditional acidic i-motif forming sequences. This work has implications not only in the epigenetic regulation of DNA, but also allows discreet tunability of i-motif stability for nanotechnological applications.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31777919 PMCID: PMC6943138 DOI: 10.1093/nar/gkz1082
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Chemical structures of cytosine and the examined epigenetic modifications. 5mC: 5-methylcytosine, 5hmC: 5-hydroxymethylcytosine; 5fC: 5-formylcytosine and 5caC: 5-carboxylcytosine.
Modification of hTeloC sequence and key describing modification type and location
| Cytosine modification | |||||
|---|---|---|---|---|---|
| Sequence (5′-3′) | Cytosine | 5mC | 5hmC | 5fC | 5caC |
| T | |||||
| C | 1 | 01mC01 | 13hmC01 | 25fC01 | 37caC01 |
| C | 2 | 02mC02 | 14hmC02 | 26fC02 | 38caC02 |
| C | 3 | 03mC03 | 15hmC03 | 27fC03 | 39caC03 |
| T | |||||
| A | Loop 1 | ||||
| A | |||||
| C | 4 | 04mC04 | 16hmC04 | 28fC04 | 40caC04 |
| C | 5 | 05mC05 | 17hmC05 | 29fC05 | 41caC05 |
| C | 6 | 06mC06 | 18hmC06 | 30fC06 | 42caC06 |
| T | |||||
| A | Loop 2 | ||||
| A | |||||
| C | 7 | 07mC07 | 19hmC07 | 31fC07 | 43caC07 |
| C | 8 | 08mC08 | 20hmC08 | 32fC08 | 44caC08 |
| C | 9 | 09mC09 | 21hmC09 | 33fC09 | 45caC09 |
| T | |||||
| A | Loop 3 | ||||
| A | |||||
| C | 10 | 10mC10 | 22hmC10 | 34fC10 | 46caC10 |
| C | 11 | 11mC11 | 23hmC11 | 35fC11 | 47caC11 |
| C | 12 | 12mC12 | 24hmC12 | 36fC12 | 48caC12 |
| A | |||||
| A | |||||
Figure 2.Transitional pH of each of the epigenetically modified (5-methylcytosine; 5-hydroxymethylcytosine; 5-formylcytosine; 5-carboxylmethylcytosine) hTeloC oligonucleotides compared to the unmodified control sequence (line). Cytosines are numbered from 5′- to 3′-.
Figure 3.Melting temperature of each of the epigenetically modified (5-methylcytosine; 5-hydroxymethylcytosine; 5-formylcytosine; 5-carboxylmethylcytosine) hTeloC oligonucleotides compared to the unmodified control sequence (line). Cytosines are numbered from 5′- to 3′-.
Figure 4.Difference in enthalpy and entropy change calculated for each of the epigenetically modified (5-methylcytosine; 5-hydroxymethylcytosine; 5-formylcytosine; 5-carboxylmethylcytosine) hTeloC oligonucleotides compared to the unmodified control sequence (line). Cytosines are numbered from 5′- to 3′-